Modified release formulations of a bupropion salt

Details Modified release formulations of a bupropion salt Modified release formulations of a bupropion salt

2007-05-22

2009-08-04

Zucker, Paul A (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

Reexamination Certificate

active

07569610

ABSTRACT:
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.

REFERENCES:
patent: 5427798 (1995-06-01), Ludwig et al.
patent: 5698224 (1997-12-01), Guittard et al.
patent: 6323236 (2001-11-01), McElroy
patent: 7241805 (2007-07-01), Oberegger et al.
patent: 2005/0014743 (2005-01-01), Gupta et al.
patent: 2006/0086097 (2006-04-01), Guida
patent: 2006/0204578 (2006-09-01), Vergez et al.
patent: 2007/0026065 (2007-02-01), Benke et al.
patent: 2007/0269516 (2007-11-01), Oberegger et al.
patent: 2007/0281012 (2007-12-01), Oberegger et al.
patent: 2007/0293584 (2007-12-01), Oberegger et al.
patent: WO 03039519 A 2 (2003-05-01), None
patent: WO 2006072367 (2006-07-01), None
Berge et al. “Pharmaceutical Salts”, J.PharmSci, 66(3), 1-20, 1977.
Remington's PharmSci, 17th ed, p. 1418, 1985.
U.S. Appl. No. 11/930,644, filed Oct. 31, 2007, Oberegger, et al.
U.S. Appl. No. 11/834,848, filed Aug. 7, 2007, Oberegger, et al.
U.S. Appl. No. 11/774,109, filed Jul. 6, 2007, Oberegger, et al.
U.S. Appl. No. 11/766,239, filed Jun. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/766,213, filed Jun. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,820, filed Jun. 14, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,343, filed Jun. 13, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,840, filed Jun. 14, 2007, Oberegger, et al.
U.S. Appl. No. 11/759,413, filed Jun. 7, 2007, Oberegger, et al.
U.S. Appl. No. 11/755,946, filed May 31, 2007, Oberegger, et al.
U.S. Appl. No. 60/693,906, filed Jun. 27, 2005, Oberegger, et al.
U.S. Appl. No. 11/993,723, filed Dec. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/768,764, filed Jun. 26, 2007, Nighiem, et al.
U.S. Appl. No. 11/751,785, filed May 22, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,368, filed Jun. 13, 2007, Oberegger, et al.
U.S. Appl. No. 11/766,251, filed Jun. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/768,764, filed Jun. 26, 2007, Jackson, et al.

Affiliated with

Also associated with

Rating

Modified release formulations of a bupropion salt does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified release formulations of a bupropion salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified release formulations of a bupropion salt will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4054436